Concepedia

Akihiro Katayama

AK

Statistics

Publications

21

Citations

1.4K

H-Index

16

Active since

2001

Affiliations

Asahikawa Medical College Hospital(Current)

Okayama University

Okayama Medical Center

Roswell Park Comprehensive Cancer Center

National Hospital Organization

Akihiro Katayama is an author at Asahikawa Medical College Hospital specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2001–2023

21

Publications

21

Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice

Masayoshi Suda, Ippei Shimizu, Goro Katsuumi et al. · Nature Aging · 2021 · 266 citations

, , +9

HLA Class I Antigen Down-regulation in Primary Laryngeal Squamous Cell Carcinoma Lesions as a Poor Prognostic Marker

Takeshi Ogino, Hiroshi Shigyo, Hideyuki Ishii et al. · Cancer Research · 2006 · 190 citations · Full text

, , +16

CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer

Xinhui Wang, Takuya Osada, Yangyang Wang et al. · JNCI Journal of the National Cancer Institute · 2010 · 187 citations · Full text

, , +15

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

, , +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

, , +14

1–5 of 21